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RESUmo
O objetivo do estudo foi identificar a preva-
lência de soropositividade para as hepatite 
B e C em gestantes atendidas em uma ma-
ternidade pública do município de Catalão-
GO no período de 2005 a 2009. Estudo 
descritivo, exploratório, realizado por meio 
de consulta aos prontuários. Para a análise 
dos dados utilizou-se SPSS versão 18.0. O 
intervalo de confiança (IC) foi calculado por 
meio do teste de Person χ², considerando 
um nível de significância de 5% (p< 0,05). A 
taxa de prevalência de VHB foi de 5,64% e 
a de VHC, de 0,098%, predominantemente 
em gestantes jovens, com idade entre 20 e 
30 anos, solteiras e primigestas. 
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ABStRACt
The aim of the study was to identify the 
prevalence of hepatitis B and C sero-
positivity in pregnant women attended 
in a public maternity hospital located in 
Catalao-GO from 2005 to 2009. Descrip-
tive, exploratory study conducted through 
patients` hospital records. For data analy-
sis, we used SPSS version 18.0. The con-
fidence interval (CI) was calculated using 
the Person χ² test, considering a signifi-
cance level of 5% (p <0.05). The preva-
lence of HBV was 5.64% and HCV 0.098%, 
predominantly in young pregnant women 
aged between 20 and 30 years old, single 
and in their first pregnancy. 
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RESUmEn 
El objetivo de este estudio fue identificar 
la prevalencia de seropositividad para los 
virus de la hepatitis B y C en mujeres em-
barazadas atendidas en una maternidad 
pública de Catalão-GO entre los años 2005 
y 2009. Se trata de un estudio descriptivo-
exploratorio realizado a partir de la revi-
sión de las fichas clínicas de las pacientes. 
Para el análisis de los datos se utilizó el 
programa SPSS versión 18.0. El intervalo de 
confianza (IC) fue calculado por medio del 
test de Person χ², considerando un nivel de 
significancia de 5% (p <0,05). Las tasas de 
prevalencia de los virus de la hepatitis B y C 
fueron de  5,64% y 0,098% respectivamen-
te.  La mayor frecuencia de seropositividad 
de estos virus se observó en embarazadas 
entre 20 y 30 años, solteras y primigestas.
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intRodUCtion
Viral hepatitis are considered a serious public health 
problem in Brazil. According to the Ministry of Health, 
there are approximately two million chronic carriers of 
hepatitis B virus and three million hepatitis C carriers(1). 
The fact that they are silent infections favors the delayed 
diagnosis, resulting in the appearance of acute or chronic 
diseases that affect the liver.
The identification of the etiologic agent by means of 
serologic test allows the adoption of appropriate measures 
for prevention and control. Therefore, it is necessary that 
people regularly do tests with primary care health teams, 
which have an important role in the prevention, diagnosis, 
screening and monitoring of people with the disease.
The hepatitis B virus (HBV) is the leading cause of 
chronic liver disease worldwide. Epidemiological data es-
timate that approximately 400 million people are infected 
by this etiologic agent and that 15-40% of these individu-
als will develop cirrhosis, heart failure or hepatocellular 
carcinoma(2). Vertical transmission accounts for 35-40% of 
new cases of hepatitis B in the world, and it is through this 
type of transmission that the virus is maintained in the 
population. Chronic infection occurs in 90% of infected 
children in the neonatal period, particularly those whose 
mothers present HBsAg and HBeAg positive at birth(2).
The World Health Organization estimates the number 
at 170 million chronic carriers of hepatitis C. The hepati-
tis C virus (HCV) was identified in 1989(1), it is the main 
etiological agent of chronic hepatitis, formerly known as 
non-A, non-B. Its intrauterine transmission is uncommon 
and infection occurs primarily parenterally, affecting users 
of intravenous or inhaled drugs, people with tattoos and 
piercings or showing other forms of dermal exposure and 
also individuals who received blood transfusions before 
1993. It is assumed that HCV is largely responsible for cir-
rhosis and liver transplantation in the Western world(1).
In April 2006, Ordinance No. 2669, the Ministry of 
Health published the Pact for Health, whose priorities are 
health promotion, strengthening of primary care, elderly 
health, reducing child and maternal mortality and capac-
ity for building responses to emerging diseases such as 
hepatitis B and C confirmed by serology(3). In the latter 
case, it was proposed that goals that portray the reality of 
each Brazilian state should be formulated.
In relation to the goals proposed by the Pact for Life, 
which integrates the Pact for Health, for the state of Goias, 
it appears that those targets were not reached, whereas 
only 77% of reported cases of hepatitis B had confirmed 
serology in 2011, from the 5,980 cases reported in SINAN, 
70% had inconclusive results or no etiologic classifica-
tion, which shows that the indicator does not represent 
the epidemiological reality of the state. Still in the state 
of Goias, the detection rate for hepatitis B (per 100,000 
inhabitants) in 2005 was 0.32, in 2009 was 0.28 and in 
2011 was 0.34. The state has 246 municipalities and ap-
proximately 6,154,996 inhabitants(4-5).
The hepatitis B vaccine is highly immunogenic and in-
duces the formation of antibodies (anti-HBs) against the 
surface antigen of hepatitis B (HBsAg). As years go by and 
people age, the vaccine response decreases, for instance, 
from 90% in adolescents and young adults, the vaccine 
response falls to 70% in people aged 50-59 years. In ad-
dition, there are other factors influencing the immuno-
genicity of the vaccine such as smoking, obesity, diabetes 
mellitus and HIV infection(6). Studies have found that im-
munization of the mother against hepatitis B during preg-
nancy is safe and that the primary infant immunization 
with a recombinant vaccine confers long-term protection 
against clinical disease and chronic infection(7).
In Brazil, among the existing challenges to prevent 
transmission of the hepatitis B virus, in the period from 
2011 to 2012 the target was 100% vaccination coverage 
for pregnant women, about ten years ago, this coverage 
was 90.9%(4,8). The Centers for Disease Control and Pre-
vention, the American College of Obstetricians and Gyne-
cologists and the Brazilian Ministry of Health recommend 
immunoprophylaxis with vaccine administration in the 
first 12 hours of life, associated with specific hyperim-
mune hepatitis B immunoglobulin (HBIG) for newborns 
of pregnant women with HBV(9). This approach prevents 
infection in over 90% of cases. In the U.S., 81% of obstetri-
cians recommend the hepatitis B vaccine(9).
The gestational period is not free from infections that 
put the maternal-fetal health at risk. Pregnant women, 
when affected by infections caused by etiologic agents, as 
hepatitis B and C, may transmit them vertically, and such 
transmission may occur during pregnancy, at birth or dur-
ing breastfeeding(10).
Vertical transmission has great importance in the epi-
demiology of viral hepatitis. In the general population, the 
chances of an infection by HBV viruses to evolve to the 
chronic form in adults is 5-10%, while for the offspring of 
infected mothers, this risk is approximately 90%(11).
The neonatal HBV infection most oftenly is asymptomat-
ic and the disease progresses insidiously. The late diagnosis 
increases the risk of complications and increases morbidity 
and mortality. In children infected by vertical transmission 
of HBV, the risk of developing hepatocellular carcinoma is 
about 200 times higher than general population(9).
The HCV vertical transmission is rare in comparison 
to hepatitis B. Pregnant women with high viral load of 
HCV or co-infected with HIV have a higher risk of vertical 
transmission. Epidemiological data show that in 70-85% 
of cases become chronic occurs with a quarter to a third 
of them, on average, evolving to a pattern of moderate to 
severe histological impairment requiring treatment. The 
remainder evolves more slowly(1).
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In the state of Mato Grosso do Sul, the Association of 
Parents and Friends of Exceptional Children (APAE) at Cam-
po Grande deployed the Maternity Protection Program, 
popularly known as Mammy-Tests or Prenatal Screening, 
which favors adhesion of pregnant women to prenatal care 
immediately after the confirmation of pregnancy. Due to 
the success achieved in September 2003, the program was 
also implemented in the State of Goias(12).
The Ministry of Health, through the Ordinance GM/MS 
No. 569/GM of 2002(8), established the Program for Hu-
manization of Prenatal and Birth (PHPN) due to the need 
for improved prenatal care. The program aims to reduce 
the rates of maternal and perinatal morbidity and mor-
tality, expanding access of pregnant women to prenatal, 
obstetric and neonatal assistance(8).
Health professionals play a role as caregivers and there-
fore, must reflect on the humanization of prenatal care and 
establish a trusting relationship with clients in order to pre-
vent and control injuries to women during pregnancy and 
the postpartum period, ensuring their right to safe moth-
erhood(8). A wide prenatal screening, including serological 
tests, enables the prevention and early treatment of diseas-
es vertically transmitted to the fetus. The lack of knowledge 
and availability of preventive measures against infection by 
the hepatitis B and C are a serious public health problem, 
mainly because they are silent diseases.
Given the above, the objectives of this study were to 
identify the prevalence of HBV and HCV seropositivity in 
pregnant women attending a public maternity hospital 
located in Catalao-GO in the period 2005-2009, from the 
results of serology obtained from the records, and charac-
terize the HBV and HCV positive pregnant women. 
mEtHod
Descriptive, exploratory study with pregnant women 
in the period from 2005 to 2009 in a public hospital in the 
city of Catalao in the state of Goias, which attend women 
of urban and rural areas of the municipality, neighboring 
cities and the adjacent districts.
Data collection was conducted from June 2010 to 
November 2011 from patients’ medical records, through 
a collection instrument previously validated, containing 
identification data (age, place of birth, profession, marital 
status) and pregnancy information (gestational age, num-
ber of pregnancies, type of delivery, and whether or not 
prenatal care was done, number of consultations, labora-
tory tests carried out in prenatal care).
During prenatal care, health centers in Goias, perform 
tests of maternal diseases and serological tests that diag-
nose nine types of vertical transmission diseases, includ-
ing hepatitis B and C. Collection is conducted in phases, 
with a minimum interval of 60 days. At first, preferably 
up to 12 weeks of gestational age, the goal is to detect 
toxoplasmosis (IGG and IGM), rubella (IGG and IGM), cy-
tomegalovirus (IGG and IGM), syphilis, HIV 1 and 2, Cha-
gas’ disease, hepatitis B and C and HTLV 1 and 2. The sec-
ond, between 28 and 30 weeks of gestation, focus on the 
detection of syphilis and HIV.
Before the collection, filling the form for registration of 
pregnant women in SISPRENATAL is required. After that, the 
collection on filter paper obtained from peripheral blood 
by puncture with a sterile lancet, usually in the pregnant 
woman’s ring finger, or through venipuncture is performed. 
The material is packaged to dry for 1 hour, then it is placed 
in an envelope and mailed to the laboratory APAE Goiania, 
where the tests are performed, the results returned for 
the disposal unit in 15 to 20 days. If the result is positive 
or doubtful for one or more injuries in this initial screen-
ing, the woman is subjected to another test to confirm the 
diagnosis. In case it is positive, the mother is referred to be 
monitored by a multidisciplinary team of APAE Goiania, in 
case the municipality does not rely on specialized profes-
sional to meet the pregnant woman needs.
The study was approved by the Ethics Committee in 
Research of the Federal University of Goias, protocol No. 
043/2009. The study was based on the guidelines and 
standards for research involving human beings, which are 
CNS Resolution 466/2012. The legal representatives of the 
maternal public hospital, the City Health Department and 
the Institute of Diagnostics and Prevention APAE Goiania 
were informed about the objectives of the research and 
the Consent Form (CF) was signed after being informed 
about the possible risks and benefits of the study.
The data were tabulated in an electronic spreadsheet 
and we used the version 18.0 of the Statistical Package for 
the Social Sciences (SPSS) for the analysis. The confidence 
interval (CI) was calculated using the Person χ² Test, con-
sidering a significance level of 5% (p<0.05). 
RESULtS
The patients` medical records of 2,037 women were 
consulted, whose age ranged 13-40 years old. Table 1 sum-
marizes the characteristics of mothers of 105 positive cases 
for anti-HBc (p=0.41) found among 1,303 pregnant women 
who were examined, of which 720 were aged between 21-
30 years, age group in which there was higher frequency of 
seropositive cases (n=56, 7.8%). Further 10 positive cases 
were found for HBsAg (p=0.36) among the 1,643 women 
who were examined. In this test, it was also observed with 
more frequency (n=6, 0.7%) from 21 to 30 years, among 909 
pregnant women in this age range. 
From 1,641 women who underwent anti-HCV test, two 
positive cases were identified: in one case, the mother was 
less than 20 years old and, on the other, she was between 21 
and 30 years old. During the study period from 2005 to 2009, 
prevalence rate (PR) was 5.64% for HBV and 0.098% for HCV.
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Table 1 - Characterization of pregnant women enrolled from August 2005 to December 2009, with positive anti-HBc, HBsAg and 
anti-HCV - Catalao, GO, Brazil 2012 
Anti- HBc HBsAg Anti-HCV
N n positive (%) P N n positive (%) P N n positive (%) p
Age 0.41 0.36 0.89
<20 382 27   7.1 475 1 0.2 475 1 0.2
21-30 720 56   7.8 909 6 0.7 910 1 0.1
31-39 184 20 10.9 235 3 1.3 232 0 0.0
>40 17 2 11.8 24 0 0 24 0 0.0
Total 1.303 105 37.6 1.643 10 2.2 1641 2 0.3
Marital status 0.09 0.86 0.67
Married 469 31 6.6 659 6 0.9 658 0 0.0
Single 522 41 7.8 623 2 0.3 622 2 0.3
Divorced 9 2 22.2 11 0 0.0 11 0 0.0
Separated 4 1 25.0 4 0 0.0 4 0 0.0
Stable Union 279 30 10.7 319 2 0.6 319 0 0.0
Total 1.283 105 72.3 1616 10 1.8 1614 2 0.3
Type of Labor 0.34 0.33 0.73
Surgical 615 53 8.6 777 6 0.7 776 1 0.1
Not surgical 651 51 7.8 829 4 0.4 828 1 0.1
Total 1.266 104 16.4 1606 10 1.1 1604 2 0.2
Among 105 seropositive women for anti-HBc, 41 posi-
tive cases (p=0.09) were single. From 09 divorced wom-
en, 02 (22.0%) were seropositive, and the 04 separated 
women, 01 (25.0%) was seropositive. As for HBsAg, the 
largest number of cases occurred in married women: 6 in 
10 (p=0.86). Two positive cases were reported to anti-HCV 
(p=0.67) among single women. 
Regarding occupation, among the 899 women who 
were devoted to household services, there were 72 positive 
cases for anti-HBc (p=0.78). We observed 8 HBsAg positive 
cases among the 1,117 women tested (p = 0.00). There 
was no case registered among the 1,113 women tested for 
anti-HCV (p = 1.00). Among women who had activities out-
side the home, 25 positive cases for anti-HBc among 325 
women; two positive cases for HBsAg among 430 tests and 
a case for anti-HCV of 430 pregnant women studied.
Regarding the number of abortions, the incidence was 
higher in women under 20 years, registering 10 positive 
cases out of a total of 179 anti-HBc (p=0.57) and 1 positive 
case for HBsAg (p=0,99).
Figure 1 – Number of prenatal consultations performed by seropositive pregnant women for anti-HBc, from August 2005 to December 2009 - Catalao, GO, 
Brazil, 2012. 
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Figure 2 – Number of prenatal consultations by seropositive pregnant women for HBsAg, from August 2005 to December 2009 - Catalao, GO, Brazil, 2012 
There was no significant difference in the association 
between age, profession, marital status and being positive 
for anti-HBc, HBsAg and anti-HCV (p>0.05). From the 105 
seropositive women for anti-HBc, 100 underwent prena-
tal care, as well as all 10 seropositive for HBsAg, revealing 
great adhesion of these women to the basic care service 
(Figures 1 and 2). 
The two seropositive pregnant women for anti-HCV 
underwent prenatal care (p=0.98). When we considered 
the number of pregnancies, the largest number of posi-
tive cases for anti-HBc involved primiparous, totaling 36 
out of the 105 seropositives women (p=0.72). The same 
occurred with the HBsAg-positive mothers, with 4 cases 
of first pregnancy among 10 seropositive (p=0.99). In se-
ropositive pregnant women for anti-HCV (p=0.99) a rate of 
50% in their first pregnancy was observed.
Regarding the type of delivery from 105 women posi-
tive for anti-HBc (p=0.34) 53 underwent surgical delivery 
and 51 non-surgical delivery. From the 10 women positive 
for HBsAg (p=0.33) 6 carried surgical delivery, and 4 non-
surgical delivery, the two women positive for anti-HCV, 
one performed surgical delivery, and the other non-surgi-
cal delivery (p=0.73). 
diSCUSSion
The results showed higher rates of seropositivity in 
young pregnant women, aged between 21 and 30 years: 
4.75% of positive cases for HBV and 0.3% for HCV. A 
similar situation was observed in a study conducted in 
Ribeirao Preto in which 5,191 patients were evaluated, 
with a mean age of 24.6 years with a range of variation 
12-51 years, of whom 30% were young women with 
up to 20 years and 78,5%, up to 29 years. We detected 
26 carriers of HBsAg antigen, with a prevalence rate of 
0.5%. Vertical transmission was not the main factor of 
transmission of hepatitis B in the community, although 
not ruled out its participation as an important factor per-
petuating viral diseases(11).
In the present investigation, among seropositive wom-
en for Anti-HBc, the percentage of single and married 
women was relatively close (6.6% and 7.8%, respectively). 
We observed a higher frequency of positive HBsAg among 
married (0.09%). These data should be carefully consid-
ered, since the study did not test whether women who 
identified themselves as single lived in a stable union, be-
cause this information was not available in the patients’ 
medical records, in which lack of standardization of re-
corded information and on relevant aspects of the sexual 
history of the woman was observed.
The scientific literature has shown that being mar-
ried or being in a stable union is not a protective factor 
against STDs, since the woman can be monogamous but 
not her partner. The stable relationship in general is as-
sociated with feelings of security and women and their 
partners may not take measures to protect themselves 
against STDs(13). Another aspect that must be considered 
is the cultural influence, showing a distinct sexual behav-
ior before and after the diagnosis of an STD, such as the 
adoption of protective measures and more critical think-
ing regarding their own health status and submission to 
the wishes of partner during sexual intercourse(14).
Another factor that has not been shown is related to 
the communication of STDs diagnosis to sexual partners(13). 
This behavior may be explained by the low understanding 
of the mechanism of transmission of diseases, fear of losing 
the partner or the financial dependence that is established 
in some relationships. This situation represents a major 
challenge to break the chain of transmission. Thus, it is es-
sential to take into account cultural considerations, beliefs, 
gender relations and power in the approach and monitor-
ing of pregnant women, especially those with STD.
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Still on data related to characterization of marital sta-
tus and seropositivity, attention should be paid to the 
high seropositivity for anti-HBc among divorced (22.2 %) 
or separated (25.0%) women. These data are significant 
because they may signal the need for the development 
of specific strategies to the guidance of these pregnant 
women in health services related to prevention, protec-
tion and transmission of STDs.
As the study did not assess the sexual habits of preg-
nant women, we cannot make any inferences about the 
causal relationship between the data and the adoption or 
otherwise measures of sexual protection, number of part-
ners, contamination before or after divorce or separation 
and route of contamination by hepatitis viruses B and C. 
A study conducted in the state of Ceara, with pregnant 
women in the cities of Fortaleza and Aracati, it was found 
that, among the risk factors associated with STDs, being 
single, widowed or divorced made women from these cit-
ies more prone to contract an STD (p<0.001)(15).
In the present investigation, a prevalence rate of 5.64% 
to 0.098% for HBV and HCV was identified. In a study con-
ducted in Sudan with 728 pregnant women, about 5% 
were HBsAg and less than 1%, HCV-positive, none of the 
risk factors(16).
There was a predominance of positive cases among 
women who were pregnant for the first time. The same 
occurred in a research developed in Mato Grosso do Sul 
with 32,512 pregnant women(10). The frequency of HB-
sAg was 0.3% among pregnant women aged 11 to 49 
years, mean age at diagnosis was 24.2±4.8 years, the ma-
jority of seropositive pregnant women were pregnant for 
the first time, and the 1st trimester of pregnancy was the 
predominant period for the diagnosis of hepatitis B (38.6 
%). For anti-HCV, the observed frequency was 0.1% and 
the age of seropositive pregnant women ranged from 17 
to 34 years, with a mean of 25 ± 4.1 years.
There was no significant difference between the age of 
the pregnant women and the presence of infection with 
hepatitis B and C(10). Similar results were obtained in a 
study in which the prevalence of anti-HCV was 0.15% and 
half of seropositive women were primiparous and 11% re-
ported four or more pregnancies(17).
In the present investigation, the largest number of 
positive cases for anti-HBc and HBsAg was found in young, 
primiparous women. This fact can be explained by insuffi-
cient vaccination of adolescents and adults at high risk for 
infection and lack of information, care, prevention and im-
plementing strategies to better accommodate these preg-
nant women. Although knowledge about hepatitis B has 
been demonstrating progress, there are still many ques-
tions, always requiring new studies and new approaches 
to educational measures.
Research conducted in prenatal service of Sao Paulo, 
in which 47 pregnant women attended by obstetric nurses 
were analyzed, all proved susceptible to hepatitis B virus. 
Among them, 19 (40.5%) were primiparous(18).
In this study from the 1,303 pregnant women that un-
derwent test for anti-HBc, 17% were over 40 years old. 
From the 1,643 pregnant women who underwent screen-
ing for HBsAg, 24% were over 40 years old, and for anti-
HCV, 24% pregnant women were also over 40 years old. 
This age group showed a lower frequency of pregnant 
women in the analyzed period.
Study performed in a metropolitan hospital of Sarandi-
PR revealed that pregnancy in women over 35 years is in-
creasingly common in obstetric practice reality, because 
the higher educational levels may represent a stimulus for 
postponing pregnancy and unprotected sex does not hap-
pen so early. In contrast, in women over 35 years, there 
was a greater frequency of adverse perinatal outcomes 
such as low birth-weight infants, preterm or post-term 
birth. Thus, health professionals, responsible for the care 
of these women, need to be aware of the characteristics 
of pregnancy at that stage of life(19).
In 1986, the percentage of pregnant women who 
had never visited a doctor was 26%, in 2006, accord-
ing to the National Demographic and Health Survey 
(PNDS), this percentage decreased to 1.3% and at least 
61% of the pregnant women had undergone seven or 
more visits to the doctor, including the exams. It is not-
ed, therefore, that apart from the increase in the num-
ber of women attended, there was an increase in the 
supply of services provided by health units in relation 
to women’s health(20).
In the present study, most of the women had at least 
6 prenatal consultations, which shows high adhesion to 
service. Regarding the prevalence rate for HBV (5.64%), 
this proved to be inferior to a study that found an average 
prevalence rate of 15.5% for hepatitis B among women in 
Taiwan and 8.9% among southeast Asian(21).
Among pregnant women in Catalao-GO, the frequency 
of soropositivity for anti-HCV was 0.3%, result consistent 
with a study conducted in the city of Lorestan in western 
Iran, which identified the frequency of 0.2% of seroposi-
tivity for anti-HCV outcome in pregnant women(22).
In positive HBV cases analyzed in this study, there was 
little difference between the number of cesarean sections 
(n=59) and non-surgical deliveries (n=55). Among the pos-
itive cases for HCV, there was no difference between the 
number of cesarean section (n=1) and non-surgical (n=1) 
births.
Cesarean section presents similar risk to natural child-
birth in the transmission of infection and, despite the 
presence of HBV in human milk, it appears to be no sig-
nificant increase in transmission through this pathway in 
the absence of fissures and breast lesions; breastfeeding 
showed no increase in the frequency of infection even 
in non-vaccinated newborns, despite that the carriers 
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mothers milk contain HBsAg. It is believed, however, that 
there is the possibility of contamination when the milk is 
offered to non-vaccinated infants(9).
The main moment for the contamination of the 
newborn is during labor, cesarean or vaginal delivery. 
Transmission from mother to child occurs in 90% of 
cases where the mother is seropositive for HBsAg and 
HBeAg, and in 10% of cases of seropositivity only for 
HBsAg(23). Thus, the World Health Organization and UNI-
CEF recommend exclusive breastfeeding, even in highly 
endemic regions, independent of immunoprophylaxis, 
because of the high morbidity and mortality in children 
who are not breastfed(9).  
ConCLUSion
The study allowed us to identify and characterize sero-
positive  pregnant women for HBV and HCV and released 
for the first time data on the prevalence of seropositivity 
among pregnant women in the city of Catalao-GO, Thus, 
we hope to have provided bases for planning follow-up 
activities of women living with hepatitis B and C viruses, 
as well as actions to prevent transmission. 
The fact the information contained in the patients’ 
medical records is not described in a standardized way 
hindered the elucidation of aspects relevant to the study, 
which emphasizes the importance of health professionals 
to realize the clear record of data in patients` medical re-
cords of pregnant women.
In order to increase the quality of services provided to 
the health of pregnant women, there is still a long way 
to go, which includes investments in the continuing edu-
cation of health professionals, valuing aspects related to 
the beliefs and culture on health and disease of pregnant 
women attended, either in welcoming or monitoring, ac-
tive surveillance for agents in pregnant women, early di-
agnosis and timely treatment to prevent vertical transmis-
sion of infectious diseases such as hepatitis B and C. 
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